Low Serum Creatine Kinase Levels in Breast Cancer Patients: a Case-control Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Apr 25

PMID 23614022

Citations 14

Authors

Hong Pan

Kai Xia

Wenbin Zhou

Jinqiu Xue

Xiuqing Liang

Lin Cheng

Naping Wu

Mengdi Liang

Dan Wu

Lijun Ling

Qiang Ding

Lin Chen

Xiaoming Zha

Xiaoan Liu

Shui Wang

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies provide an ambiguous picture of creatine kinase (CK) expression and activities in malignancy. The aim of this study was to investigate the role of serum CK level in breast cancer patients.

Patients And Methods: 823 female patients diagnosed with breast cancer were consecutively recruited as cases, and 823 age-match patients with benign breast disease were selected as controls. Serum CK was analyzed by commercially available standardized methods.

Results: Serum CK level was significantly associated with breast cancer (P = 0.005) and subtypes of breast cancer, including breast cancer with diameter>2 cm (P = 0.031) and stage IIIbreast cancer (P = 0.025). The mean serum CK level in patients with>2 cm tumor was significantly lower than that in≤2 cm (P = 0.0475), and the mean serum CK level of stage III breast cancer patients was significantly lower than that of stage I and II breast cancer patients (P = 0.0246). Furthermore, a significant difference (P = 0.004) was observed between serum CK level and ERBB2+breast cancer not other molecular subtypes.

Conclusions: Serum CK levels in cases was significantly lower compared with controls. Notably, our results indicated for the first time that there was a negative correlation between serum CK levels and breast cancer stage. Serum CK level, which may reflect the status of host immunity, may be an important factor in determining breast cancer development and progression.

Citing Articles

Evaluation of prognostic risk factors of triple-negative breast cancer with F-FDG PET/CT parameters, clinical pathological features and biochemical indicators.

Zhu L, Yang X, Zhang J, Wang S, Wang Y, Wan X Front Cell Dev Biol. 2024; 12:1421981.

PMID: 39296933 PMC: 11408346. DOI: 10.3389/fcell.2024.1421981.

Low serum creatine kinase level is associated with poor prognosis in patients with hepatocellular carcinoma: A retrospective single‑center study.

Matsumoto Y, Otsuka Y, Okada R, Ito Y, Kimura K, Ishii J Oncol Lett. 2024; 28(4):454.

PMID: 39100994 PMC: 11292462. DOI: 10.3892/ol.2024.14587.

Analysis of clinical factors impacting recurrence in myxofibrosarcoma.

Chen W, Ye M, Sun Y, Wei Y, Huang Y Sci Rep. 2024; 14(1):3903.

PMID: 38365844 PMC: 10873400. DOI: 10.1038/s41598-024-53606-y.

Preoperative low plasma creatine kinase levels predict worse survival outcomes in bladder cancer after radical cystectomy.

Li Y, Xu H, Lin T, Zhang J, Ai J, Zhang S Int Urol Nephrol. 2024; 56(7):2215-2225.

PMID: 38315281 DOI: 10.1007/s11255-024-03957-2.

A high serum creatine kinase (CK)-MB-to-total-CK ratio in patients with pancreatic cancer: a novel application of a traditional marker in predicting malignancy of pancreatic masses?.

Chen C, Lin X, Lin R, Huang H, Lu F World J Surg Oncol. 2023; 21(1):13.

PMID: 36653771 PMC: 9847085. DOI: 10.1186/s12957-023-02903-3.

References

Hubbard S, Till J . Protein tyrosine kinase structure and function. Annu Rev Biochem. 2000; 69:373-98. DOI: 10.1146/annurev.biochem.69.1.373. View

DINNING J, SEAGER L . An elevated excretion of creatine associated with leukemia in mice. Science. 1951; 114(2967):502-3. DOI: 10.1126/science.114.2967.502. View

Zhang Y, Li H, Wang X, Gao X, Liu X . Regulation of T cell development and activation by creatine kinase B. PLoS One. 2009; 4(4):e5000. PMC: 2659424. DOI: 10.1371/journal.pone.0005000. View

Patra S, Bera S, SinhaRoy S, Ghoshal S, Ray S, Basu A . Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma. FEBS J. 2008; 275(12):3236-47. DOI: 10.1111/j.1742-4658.2008.06475.x. View

Wallimann T, Hemmer W . Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem. 1994; 133-134:193-220. DOI: 10.1007/BF01267955. View

Gao Y, Zhang D, Li H, Liu R, Zhuang Z, Li Q . Proteomic approach for caudal trauma-induced acute phase proteins reveals that creatine kinase is a key acute phase protein in amphioxus humoral fluid. J Proteome Res. 2007; 6(11):4321-9. DOI: 10.1021/pr070504x. View

Pickering L, Pang H, Biemann K, Munro H, Schimmel P . Two tissue-specific isozymes of creatine kinase have closely matched amino acid sequences. Proc Natl Acad Sci U S A. 1985; 82(8):2310-4. PMC: 397547. DOI: 10.1073/pnas.82.8.2310. View

Lehnhardt F, Bock C, Rohn G, Ernestus R, Hoehn M . Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed. 2005; 18(6):371-82. DOI: 10.1002/nbm.968. View

Wallimann T, Turner D, Eppenberger H . Localization of creatine kinase isoenzymes in myofibrils. I. Chicken skeletal muscle. J Cell Biol. 1977; 75(2 Pt 1):297-317. PMC: 2109934. DOI: 10.1083/jcb.75.2.297. View

10.

Kuum M, Kaasik A, Joubert F, Ventura-Clapier R, Veksler V . Energetic state is a strong regulator of sarcoplasmic reticulum Ca2+ loss in cardiac muscle: different efficiencies of different energy sources. Cardiovasc Res. 2009; 83(1):89-96. DOI: 10.1093/cvr/cvp125. View

11.

Cramer D, Finn O . Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol. 2011; 23(2):265-71. PMC: 3073666. DOI: 10.1016/j.coi.2011.01.002. View

12.

Vivier E, Raulet D, Moretta A, Caligiuri M, Zitvogel L, Lanier L . Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331(6013):44-9. PMC: 3089969. DOI: 10.1126/science.1198687. View

13.

Disis M, Bernhard H, Shiota F, Hand S, Gralow J, Huseby E . Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood. 1996; 88(1):202-10. View

14.

Peoples G, Goedegebuure P, Smith R, Linehan D, Yoshino I, Eberlein T . Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci U S A. 1995; 92(2):432-6. PMC: 42754. DOI: 10.1073/pnas.92.2.432. View

15.

Benson J, Jatoi I . The global breast cancer burden. Future Oncol. 2012; 8(6):697-702. DOI: 10.2217/fon.12.61. View

16.

Zhang H, Liu X, Zhang B, Peng X, Li H . Amphioxus CaVPT and creatine kinase are crucial immune-related molecules in response to bacterial infection and immunization. Fish Shellfish Immunol. 2012; 33(5):1139-48. DOI: 10.1016/j.fsi.2012.08.025. View

17.

Yanokura M, Sawai Y, Tsukada K . The uptake of creatine by various tissues from a mouse bearing tumor cells. Biochim Biophys Acta. 1984; 797(1):94-8. DOI: 10.1016/0304-4165(84)90386-6. View

18.

Kinoshita Y, Yokota A . Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10(1):2-12. DOI: 10.1002/(sici)1099-1492(199701)10:1<2::aid-nbm442>3.0.co;2-n. View

19.

Patra S, Ghosh A, Roy S, Bera S, Das M, Talukdar D . A short review on creatine-creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy. Amino Acids. 2011; 42(6):2319-30. DOI: 10.1007/s00726-011-0974-3. View

20.

Joseph J, Cardesa A, Carreras J . Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas. Br J Cancer. 1997; 76(5):600-5. PMC: 2228007. DOI: 10.1038/bjc.1997.432. View